AI assistant
Biocon Ltd. — Regulatory Filings 2021
Nov 11, 2021
61176_rns_2021-11-11_4a984843-4b24-4a41-9393-0daf1f0bfb30.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
==> picture [102 x 40] intentionally omitted <==
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417
www.biocon.com
November 11, 2021
| To The Secretary BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers, Dalal Street,Mumbai – 400 001 |
To The Secretary National Stock Exchange of India Limited Corporate Communication Department Exchange Plaza, Bandra Kurla Complex Mumbai – 400 050 |
|---|---|
| Scrip Code - 532523 | Scrip Symbol - BIOCON |
Dear Sir/Madam,
Sub: Meeting conducted with Institutional Investors/Research Analysts.
Ref: Revised Intimation under Regulation 30 (6) of SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015.
Pursuant to Regulation 30 (6) of the SEBI LODR Regulations, 2015, we hereby inform you that the following meeting was conducted with Institutional Investor / Research Analysts:
| Date | Name | Type of meeting | Location |
|---|---|---|---|
| November 10, 2021 | ApaH Capital Management Limited | Teleconference | Bangalore |
| Myriad Asset Management Limited |
We request you to kindly take above intimation on record.
Thanking You,
Yours faithfully,
For Biocon Limited
==> picture [72 x 32] intentionally omitted <==
==> picture [73 x 77] intentionally omitted <==
Mayank Verma Company Secretary and Compliance Officer